DIS3 and osteosarcoma: We hence knocked down DIS3 in human osteosarcoma U2OS cells, in human kidney embryonic HEK-293T cells and in mouse embryonic fibroblast NIH3T3 cells, using an shRNA targeting respectively the DIS3 human (shRNA4) and Dis3 mouse sequence (Figure 2A).